Generic Name and Formulations:
Oxybutynin chloride 10% (1g/sachet); topical gel; contains alcohol.
Indications for GELNIQUE:
Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency.
Apply 1g gel (one sachet) once daily to dry, intact skin on abdomen, upper arm/shoulders, or thighs. Rotate application sites; avoid use of same site on consecutive days. Wash hands after application. Avoid washing area/showering for 1hr after application.
Urinary or gastric retention. Uncontrolled narrow angle glaucoma.
Bladder outflow obstruction. Gastrointestinal obstruction. Decreased GI motility. Ulcerative colitis. Intestinal antony. Gastroesophageal reflux. Esophagitis. Hepatic or renal dysfunction. Myasthenia gravis. Controlled narrow angle glaucoma. Discontinue if skin hypersensitivity or angioedema develops; consider discontinuing if anticholineric CNS effects occur. Skin transference: cover application site with clothing after gel has dried if direct contact is anticipated. Exposure to high environmental temperatures. Gel is flammable. Pregnancy (Cat.B). Nursing mothers.
Caution with drugs that can cause or exacerbate esophagitis (eg, bisphosphonates). Additive effects with other anticholinergics.
Dry mouth, application site reactions (eg, pruritus, dermatitis), urinary tract infection, dizziness, nasopharyngitis, fatigue, headache, constipation, other anticholinergic effects (eg, CNS).
Gel (1g/sachet)—30; Gel 3% pump—92g
- 30 packets of 10% cartons (Qty:1)
- appx. price $283.00
- Kalydeco sNDA Granted Priority Review for Expanded Indication
- Wearable Patches for Vital Signs Outperform Traditional Devices in Study
- Single-Dose Antibiotic for ABSSSI, Including MRSA, Accepted for Review
- Palivizumab Found to Reduce Hospitalizations Due to Severe RSV-Associated Acute Lower Respiratory Tract Infections
- Combo Tx Doesn't Improve Survival in Patients with Gram-Negative Bloodstream Infections